Metadata

title
CRISPR screens in human neural organoids and assembloids
kind
paper
status
ingested
added
2026-04-08T15:46:54+09:00
raw source
raw/sources/meng_2025_crispr_screens_in_human_neural.pdf
article url
https://www.nature.com/articles/s41596-025-01299-6
published date
2025-12-19
organ
brain
protocol focus
CRISPR screening in neural organoids and assembloids
deep ingested
2026-04-08

Source

Study design

  • Starting material: pre-established organoids prepared for perturbation, editing, or screening
  • Protocol type: engineering, imaging, or perturbation protocol layered onto organoid culture
  • Aim: CRISPR screening in neural organoids and assembloids
  • Core readouts: pooled perturbation, selection, and follow-up validation workflows

Summary

  • This paper is best understood as an engineering, imaging, or perturbation protocol layered onto organoid culture for CRISPR screening in neural organoids and assembloids.
  • Its main distinctive contribution in this corpus is that it turns neural organoids and assembloids into pooled CRISPR screening systems.
  • Within this collection, it belongs to the engineering and readout-expansion branch of organoid protocol work.
  • Paper framing: • We present pooled CRISPR- Studying the molecular mechanisms underlying the assembly of the human Cas9 screening with neural nervous system remains a significant challenge. The ability to generate neural organoid and assembloid models.

Key findings

  • Defines a workflow centered on CRISPR screening in neural organoids and assembloids.
  • Its distinctive focus in practice is the way it turns neural organoids and assembloids into pooled CRISPR screening systems.
  • Adds a leverage layer such as imaging, editing, or screening that turns organoids into more mechanistic systems.

Strengths

  • Adds a reusable perturbation or imaging layer that increases experimental leverage.
  • Makes organoids more compatible with mechanistic and platform-style studies.

Limitations and caveats

  • Usually assumes that the baseline organoid system is already robust before engineering begins.
  • Technical failure modes may come from delivery, imaging, or screen design rather than from the organoid biology itself.

Relevance to this corpus

  • Specific role in this corpus: A high-leverage protocol when the goal shifts from making organoids to perturbing them systematically.
  • This paper broadens the collection's coverage of brain organoid work.
  • It matters because many practical organoid projects stall at the perturbation or readout stage rather than at derivation.

Open questions

  • Which engineering or readout step is most likely to fail before the biology is interpretable?
  • How should this workflow be standardized across cell lines, batches, or perturbation sets?

<!-- opendataloader:begin -->

Parsed Artifacts

These parsed files are helper artifacts. Treat the original raw PDF as the source of truth. <!-- opendataloader:end -->